Transmedtech

Transmedtech

Innovative technologies co-developed in an interdisciplinary partnership targeting better diagnostic and treatment of widespread complex diseases:

  • Musculoskeletal
  • Cardiovasuclar
  • Cancer
Transmedtech

Discover TransMedTech

Researchers, physicians, engineers, patients, students, equipment vendors, and public health system stakeholders all working together to devise the medical technologies of tomorrow...

Transmedtech

Inauguration of the TransMedTech Institute

Polytechnique Montréal and numerous partners will collaborate to devise the medical technologies of tomorrow.

Read the article

TransMedTech Institute

Mission

The mission of the TransMedTech Institute is to develop next-generation medical technologies for the diagnosis, prognosis, treatment, and rehabilitation of three major groups of diseases: cancer, cardiovascular illnesses and musculoskeletal disorders.

Informations

Research

Co-creation of solutions

The cornerstone of the TransMedTech Institute is its transdisciplinary, intersectoral, open-innovation ecosystem. Better known as a living lab, this is a new-design approach to health research and innovation.

The living-lab model collectively involves researchers, engineers, students, physicians, caregivers, industries, policy-makers, governments and patients in the rapid generation of innovative technology solutions and approaches to healthcare delivery.

Benefits

  • Accelerated processes of development, clinical validation, and transfer to the healthcare system.
  • Better matching of technology solutions to the needs of healthcare users.

Objectives

  • Promote collaborative transdisciplinary and intersectoral research as well as innovation and creativity, via the living-lab approach.
  • Accelerate transfers to industry as well as integration of novel treatment modes and new technologies into the healthcare system.
  • Target significant social and economic impacts.
  • Establish international networks and partnerships.
  • Attract and train qualified next-generation medical-technology professionals with an accent on diversity.
  • Develop a medical-technology showcase and centre of attraction.

Strategic research areas

  MUSCULOSKELETAL DISORDERS CARDIOVASCULAR DISEASES CANCER
REHABILITATION TECHNOLOGIES    
BIOSENSORS AND MEDICAL MICRODEVICES  
PROGNOSTIC TESTS FOR PROGRESSIVE PATHOLOGIES  
MINIMALLY INVASIVE TREATMENT DEVICES  
IMAGING, LASER THERAPIES, BIOPHOTONIC PROBES
NANOROBOTICS AND THERANOSTICS TECHNOLOGY
MULTIMODAL INTERVENTIONAL IMAGING
Rehabilitation technologies

Toward improved quality of life for people living with disabilities

  • Motion analysis and robotics technology for walking rehabilitation and upper-limb rehabilitation
  • Personalized assistance technologies for rehabilitation
  • Smart materials and novel manufacturing processes
Biosensors and medical microdevices

Toward new approaches to diagnosing neurological and cardiovascular diseases as well as cancer tumours

  • Personalized real-time analyses
  • Selective delivery of neurotransmitter modulators
  • Micromanufacturing and microproduction processes
Prognostic tests for progressive pathologies

Toward improved quality of life for patients with musculoskeletal disorders

  • Screening and prognostic testing
  • Shorter treatment cycles
  • Minimally invasive surgical techniques
Minimally invasive treatment devices

Toward novel treatments for joint degeneration, pediatric musculoskeletal disorders and cardiovascular diseases

  • Minimally invasive medical devices
  • Biomaterials for joint-tissue regeneration
  • Treatment devices using growth modulation
Imaging, laser therapies, biophotonic probes

Toward improved prospects of recovery via more precise and effective treatment methods

  • Next-generation optical systems for combining functional and molecular imaging and for laser therapies
  • Minimally invasive instruments for precision medicine
Nanorobotics and theranostics technology

Toward new avenues for treatment of cancer tumours

  • Integrated screening, diagnosis and treatment tools
  • Nanonavigating therapeutic agents
  • Non-invasive and more effective interventions
Multimodal interventional imaging

Toward more effective personalized treatments for cardiovascular and neuromusculoskeletal conditions

  • Multimodal imaging, augmented reality and real-time navigation tools
  • Next-generation image-guided therapies 
Team
Direction

Carl-Éric Aubin P.Eng., Ph.D.
Chief Executive and Scientific Officer
514 340-4711 ext. 2836
carl-eric.aubin@polymtl.ca
View expertise background

Geneviève Emond
Assistant to Chief Executive and Scientific Officer
(514) 345-4931 ext. 7011 (CHU Sainte-Justine)
(514) 340-4711 ext. 3739 (Polytechniuque)
genevieve.emond@polymtl.ca
Development, Partnerships and Operations

Joe-Guillaume Pelletier, Ph. D. MBA, Adm.A
Assistant Director – Development, Partnerships and Operations
(514) 318-5629
joe-guillaume.pelletier@polymtl.ca

Karine Genest, M.Sc., MBA
Manager, Administration and Finance
(438) 822-3201
karine.genest@polymtl.ca

Sylvie Forgues
Manager, Communications and Marketing
(514) 778-5680
sylvie.forgues@polymtl.ca
Living Lab Unit

Marie-Pierre Faure, Ph. D.
Assistant Director – Living Lab Unit
(514) 264-3797
marie-pierre.faure@polymtl.ca

Charles Vachon, M.Sc., MBA
Senior Advisor, Regulatory Affairs
(514) 825-4461
charles.vachon@polymtl.ca

Guillaume Roy, Ph. D.
Senior Advisor, Technology Development
(514) 261-5105
guillaume.roy@polymtl.ca
Polytechnique Montréal
Research, Innovation and International Affairs

Augustin Brais, Eng.
Directeur adjoint, Direction de la recherche, de l'innovation et des affaires internationales (DRIAI)
Polytechnique Montréal
(514) 340-3275
augustin.brais@polymtl.ca

 

Neïla Kaou, Ph. D.
Conseillère au développement et partenariats, Direction de la recherche, de l'innovation et des affaires internationales (DRIAI)
Polytechnique Montréal
(514) 340-4711 ext. 2154
neila.kaou@polymtl.ca

 

Training

Attracting, training and retaining top talents

Working at the heart of the open-innovation ecosystem at the TransMedTech Institute, students acquire exceptional scientific and entrepreneurial skills, including:

  • proficiency in basic, applied and clinical research methodologies;
  • expertise in technological innovation; and
  • understanding of challenges, concepts and cultures specific to various disciplines and areas.

Boasting some 60 researchers including leading players in their respective fields, health professionals, major names in the medical technology industry, and essential health-sector policy-makers, the TransMedTech clearly has what it takes to attract the best talents.

Partnerships

Tronsdisciplinory and intersectorol partnerships are at the heart of the TronsMedTech lnstitute scientific strotegy.

Founding institutions

 

Partners

  • Canada First Research Excellence Fund 
  • Ministère de l'Économie, de la Science et de l'lnnovation, Québec 
  • Fonds de recherche du Québec 
  • Office of the Chief Scientist, Québec 
  • MEDTEQ 
  • Univalor Fondation du CHU Sainte-Justine Fondation de Polytechnique 
  • Jewish General Hospital Foundation 
  • Fondation Mélia 
  • Université Aix-Marseille 
  • IFSTTAR 
  • CORIN 
  • lnnovitech 
  • Boston Brace 
  • Medtronic 
  • Siemens 
  • Zimmer Biomet 
  • Technoparc Montréal 
  • Centre of Excellence on Partnership with Patients and the Public 
  • National Scoliosis Foundation 
  • Scoliosis Research Society 
  • Coalition priorité cancer au Québec 
  • MIMO Study Group 
  • Q-Croc
  • AlterGO

and several other organizations in the process of joining

Press Review

MONTREAL GAZETTE | 24 April 2017

Ste-Justine Children’s Hospital inaugurates research institute | READ

Contact

Carl-Éric Aubin

Professor & Chief Executive and Scientific Director, Montreal TransMedTech Institute
Polytechnique Montréal

carl-eric.aubin@polymtl.ca
(514) 340-4711 poste 2836

Canada First Grant

Fonds d’excellence à la recherche Apogée Canada

In 2016, the TransMedTech Institute was awarded $35.6 million in funding for the next seven years by the Canada First Research Excellence Fund.